Sachem SCCD Delivers Q4 2025 Beat EPS 003 vs 000 Expected Fate Therapeutics FATE Q1 2026 Earnings Surprise EPS 026 Up Significant Arq ARQ Q1 2026 Earnings Beat Revenue NA EPS 002 Gladstone GOOD Down 169 How Low Could It Go 20260515 Azenta AZTA Surges 387 Nearing 1747 Resistance 20260518 Tavia Acquisition TAVI Stock Analysis Flat at 1060 Whats Next 20260514 Trump Gas Tax Holiday Proposal Raises Questions About Highway Trust Fund Solvency NXPL Q1 2026 Earnings Loss per Share Reported at 042 Stock Declines Gen Alpha Savings Gap Children of Gen X Parents Outsave MillennialRaised Peers by 30